New Edition of Cancer Care’s Helping Hand Available

Publication
Article
OncologyONCOLOGY Vol 16 No 8
Volume 16
Issue 8

Cancer Care has published the fourth edition of its handbook-A Helping Hand: The Resource Guide for People With Cancer. The 148-page booklet contains listings and descriptions of organizations that offer a wide variety of services, support, and information for people with cancer. In general, the booklet shows cancer patients what types of help are available to them and where they can find it, both nationally and regionally. Listings include cancer centers, commercial services that offer products of particular interest to people with cancer (such as wigs and prostheses), state pharmaceutical assistance programs, pharmaceutical manufacturers’ indigent drug programs, and useful tips on what to ask when contacting such services.

Cancer Care has published the fourth edition of itshandbook—A Helping Hand: The Resource Guide for People With Cancer. The148-page booklet contains listings and descriptions of organizations that offera wide variety of services, support, and information for people with cancer. Ingeneral, the booklet shows cancer patients what types of help are available tothem and where they can find it, both nationally and regionally. Listingsinclude cancer centers, commercial services that offer products of particularinterest to people with cancer (such as wigs and prostheses), statepharmaceutical assistance programs, pharmaceutical manufacturers’ indigentdrug programs, and useful tips on what to ask when contacting such services.

The booklet can be ordered by calling 1-800-813-4673 and is available as asearchable database on Cancer Care’s website, www.cancercare.org.

Related Videos
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
Collaboration among nurses, social workers, and others may help in safely administering outpatient bispecific T-cell engager therapy to patients.
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
D. Ross Camidge, MD, PhD, spoke about how the approval of alectinib is the beginning of multiple other approvals for patients with ALK-positive NSCLC.